skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Mouse IgG2c Fc loop residues promote greater receptor-binding affinity than mouse IgG2b or human IgG1

Journal Article · · PLoS ONE

The structures of non-human antibodies are largely unstudied despite the potential for the identification of alternative structural motifs and physical properties that will benefit a basic understanding of protein and immune system evolution as well as highlight unexplored motifs to improve therapeutic monoclonal antibody. Here we probe the structure and receptor-binding properties of the mouse IgG2c crystallizable fragment (Fc) to compare to mouse IgG2b and human IgG1 Fcs. Models of mIgG2c Fc determined by x-ray crystallography with a complex-type biantennary (to 2.05 Å) or a truncated (1)GlcNAc asparagine-linked (N)-glycan attached (to 2.04 Å) show differences in key regions related to mouse Fc γ receptor IV (mFcγRIV) binding. Mouse IgG2c forms different non-bonded interactions between the BC, DE and FG loops than the highly-conserved mIgG2b and binds to FcγRIV with 4.7-fold greater affinity in the complex-type glycoform. Secondary structural elements surrounding the Asn297 site of glycosylation form longer beta strands in the truncated mIgG2c Fc glycoform when compared to mIgG2c with the complex-type N-glycan. Solution NMR spectroscopy of the N-linked (1)GlcNAc residues show differences between mIgG2b, 2c and hIgG1 Fc that correlate to receptor binding affinity. Mutations targeting differences in mIgG2 DE and FG loops decreased affinity of mIgG2c for FcγRIV and increased affinity of mIgG2b. Changes in NMR spectra of the mutant Fc proteins mirrored these changes in affinity. Our studies identified structural and functional differences in highly conserved molecules that were not predicted from primary sequence comparison.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
National Institutes of Health (NIH); National Institute of General Medical Sciences (NIGMS); Roy J. Carver Department of Biochemistry, Biophysics & Molecular Biology at Iowa State University; USDOE
Grant/Contract Number:
R01 GM115489; GUP-48455
OSTI ID:
1433703
Journal Information:
PLoS ONE, Vol. 13, Issue 2; ISSN 1932-6203
Publisher:
Public Library of ScienceCopyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 7 works
Citation information provided by
Web of Science

References (41)

Site-directed mutagenesis by overlap extension using the polymerase chain reaction journal April 1989
Lack of Fucose on Human IgG1 N -Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity journal May 2002
Fcγ receptors as regulators of immune responses journal January 2008
Structural Comparison of Fucosylated and Nonfucosylated Fc Fragments of Human Immunoglobulin G1 journal May 2007
New insights into intra- and intermolecular interactions of immunoglobulins: crystal structure of mouse IgG2b-Fc at 2·1-Å resolution journal March 2009
Structure and function in rhodopsin: High-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line journal October 2002
Intramolecular N -Glycan/Polypeptide Interactions Observed at Multiple N -Glycan Remodeling Steps through [ 13 C, 15 N]- N -Acetylglucosamine Labeling of Immunoglobulin G1 journal December 2014
Regulated Glycosylation Patterns of IgG during Alloimmune Responses against Human Platelet Antigens journal February 2009
The Structural Role of Antibody N-Glycosylation in Receptor Interactions journal September 2015
Selective Deactivation of Serum IgG: A General Strategy for the Enhancement of Monoclonal Antibody Receptor Interactions journal June 2012
Restricted Motion of the Conserved Immunoglobulin G1 N-Glycan Is Essential for Efficient FcγRIIIa Binding journal October 2014
Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis journal March 2017
Mouse and human FcR effector functions journal October 2015
Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans: Structural basis for ADCC improvement journal October 2011
Possible allelic structure of IgG2a and IgG2c in mice journal March 2012
Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose journal July 2011
Properties of mouse and human IgG receptors and their contribution to disease models journal June 2012
TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved journal April 2008
Fc Optimization of Therapeutic Antibodies Enhances Their Ability to Kill Tumor Cells In vitro and Controls Tumor Expansion In vivo via Low-Affinity Activating Fc  Receptors journal September 2007
Carbohydrate–Polypeptide Contacts in the Antibody Receptor CD16A Identified through Solution NMR Spectroscopy journal June 2017
NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic journal January 2011
NMR Characterization of Immunoglobulin G Fc Glycan Motion on Enzymatic Sialylation journal May 2012
The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor journal August 2016
Efficient Generation of Bispecific Murine Antibodies for Pre-Clinical Investigations in Syngeneic Rodent Models journal May 2017
Structural characterization of GASDALIE Fc bound to the activating Fc receptor FcγRIIIa journal April 2016
Impact of Immune Complex Size and Glycosylation on IgG Binding to Human FcγRs journal March 2013
Decreased Levels of Bisecting GlcNAc Glycoforms of IgG Are Associated with Human Longevity journal September 2010
The Carbohydrate at FcγRIIIa Asn-162: AN ELEMENT REQUIRED FOR HIGH AFFINITY BINDING TO NON-FUCOSYLATED IgG GLYCOFORMS journal December 2005
Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors journal October 2015
Conserved FcγR- glycan discriminates between fucosylated and afucosylated IgG in humans and mice journal February 2018
Structural basis of the interaction between IgG and fcγ receptors journal January 2000
High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR journal November 2000
Modulation of protein A binding allows single-step purification of mouse bispecific antibodies that retain FcRn binding journal September 2017
Profiling IgG N-glycans as potential biomarker of chronological and biological ages: A community-based study in a Han Chinese population journal January 2016
Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge region journal March 1992
The Absence of Fucose but Not the Presence of Galactose or Bisecting N -Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity journal November 2002
Changes in Antigen-specific IgG1 Fc N-glycosylation Upon Influenza and Tetanus Vaccination journal April 2012
Clinical Severity of Visceral Leishmaniasis Is Associated with Changes in Immunoglobulin G Fc N-Glycosylation journal December 2014
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity journal April 2013
Phosphatase Wip1 in Immunity: An Overview and Update journal January 2017
High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension journal January 2015

Cited By (3)